Subscribe To
guardion health sciences announces financial results for the three months and six months ended june 30, 2023
Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2...
August 14, 2023, 12:15 pm
guardion health sciences announces financial results for the quarter ended march 31, 2023
Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022 ...
May 15, 2023, 12:15 pm
guardion health sciences, inc. announces 1-for-50 reverse stock split effective on pre-market opening on january 9, 2023
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) — guardion Health Sciences, Inc. (“...
January 6, 2023, 9:15 pm
guardion health sciences announces pricing of aggregate $4.75 million institutional private placement of series c and series d redeemable preferred stock
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) — guardion Health Sciences, Inc. (“...
November 29, 2022, 10:06 pm